Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07095062

Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.

Prospective, exploratory, multicenter pilot study investigating the structural and functional connectome in patients with Friedreich's Ataxia (FRDA) using high-density electroencephalogram (HD-EEG). The aim is to identify neurophysiological biomarkers and analyze the relationship between cortical connectivity, cognitive functioning, and clinical severity, particularly in response to rehabilitation treatment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

8 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Friedreich's Ataxia (FRDA) is a progressive neurodegenerative disease caused by mutations in the FXN gene, resulting in a reduction in the mitochondrial protein frataxin and a dysfunction in iron homeostasis. In addition to motor and sensory impairments, FRDA also results in cognitive and emotional deficits. Pathophysiologically, it is associated with cerebellar degeneration and alterations in cerebello-cortical networks.

The present study proposes a novel HD-EEG-based approach to analyze brain activity at resting-state and during the performance of a motor task (task-based) in subjects with FRDA. Thirty patients with confirmed genetic diagnosis, age between 8 and 60 years, and SARA score <30 will be recruited. EEG recordings will be performed in resting condition and during an upper limb motor task.

In addition to neurophysiological measures, each participant will undergo a comprehensive neuropsychological evaluation, including memory, attention, language, visuospatial skills, praxis, executive functions, emotional and personality aspects. Connectivity data will be correlated with cognitive profiles and scores on the SARA and mFARS clinical scales.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age between 8 and 60 years;
  • genetic diagnosis of FRDA: presence of guanine-adenine trinucleotide (GAA) expansion in the two alleles of the fratassin gene, GAA1 and GAA2;
  • score on the Scale for the Assessment and Rating of Ataxia (SARA) < 30;
  • ability to take part in a neuropsychological assessment in Italian.

Exclusion criteria

  • age different from the range 8-60 years;
  • diagnosis of acquired ataxia or other genetic ataxias;
  • SARA scale score ≥ 30;
  • inability to take part in an Italian-language neuropsychological assessment

Treatment and study plan

HD-EEG recordings, combined with cognitive and motor assessment

Device

Participants will undergo high-density EEG (HD-EEG) recordings under two conditions: at rest and while performing an upper limb motor task. The data obtained will be used to reconstruct source cortical activity and derive patterns of functional connectivity, using advanced neurophysiological analysis techniques, including the Avalanche Transition Matrix (ATM). In addition, patients will complete a neuropsychological assessment and participate in an intensive multidisciplinary rehabilitation program lasting 3 to 4 weeks, depending on age. The intervention aims to assess changes in the functional organization of the brain before and after treatment, as well as one year later, in order to explore potential biomarkers of disease progression.

Primary outcomes

  1. Connectivity profile derived from HD-EEG in subjects with FRDA.

    Time frame: From enrollment to the end of treatment at 3 to 4 weeks and after 1 year of follow-up

    Characterization of alterations in the connectome derived from the HD-EEG of subjects with FRDA compared with matched controls;

  2. Functional activity derived from HD-EEG in subjects with FRDA.

    Time frame: From enrollment to the end of treatment at 3 to 4 weeks and after 1 year of follow-up

    Evaluation of functional connectivity as a biomarker in the evolution of FRDA

Secondary outcomes

  1. Correlation between functional connectivity/activity and quantitative parameters derived from neuropsychological scales. Correlation between functional connectivity/activity and quantitative parameters derived from motor scales (SARA and mFARS).

    Time frame: From enrollment to the end of treatment at 3 to 4 weeks and after 1 year of follow-up

    • acquisition of new knowledge about the neuronal basis of impaired neurocognitive functioning in FRDA;
    • evaluation of possible correlations with disease severity scales pre- and post-rehabilitation treatment.

Study contacts

Contact information is provided by the study sponsor or research team.

Gabriella Paparella, Medical Degree

CONTACT

[email protected]

+39 04389062

Sponsors and collaborators

Lead sponsor

IRCCS Eugenio Medea

Other

Registry information

Official study title

Structural-Functional Connectome and High Density Electroencephalogram: Pilot Study in Patients With Friedreich's Ataxia.

Acronym: CONNETTOMA

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 31, 2025
Registry last updated
Jul 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.